amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
583 |
4. Check minimum number of eventsNone |
583 |
5. Include endpointsNone |
583 |
6. Filter based on genotype QC (FinnGen only) |
583 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Amyloidosis, other/unspecified
based on the number of shared cases.
Similar with more cases:
- Amyloidosis
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5263 | 2849 | 2321 |
| Only index persons | 3048 | 1579 | 1469 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.08 | 0.06 |
| Only index persons | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 67.37 | 66.72 | 68.27 |
| Only index persons | 68.90 | 67.88 | 69.99 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 583 | 282 | 301 |
| Unadjusted period prevalence (%) | 0.12 | 0.10 | 0.13 |
| Median age at first event (years) | 67.40 | 63.33 | 71.21 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 503
- Matched controls
- 5029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E85.9
ICD-10 Finland
Amyloidosis, unspecified
+∞
238.0
209
*
E85.80
ICD-10 Finland
Meretoja sick
+∞
102.7
95
*
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
+∞
100.4
93
*
E85.89
ICD-10 Finland
Other amyloidosis
+∞
91.5
85
*
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
+∞
78.2
73
*
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
+∞
78.2
73
*
H19.8*E85.80
ICD-10 Finland
Reticular keratitis in Meretoja's patients
+∞
70.5
66
*
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
+∞
63.9
60
*
C03CA01
ATC
furosemide; systemic
5.0
61.3
289
1070
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
32.9
57.8
76
27
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
33.9
55.9
73
25
XW000
NOMESCO Finland
Bone marrow biopsy
13.0
49.1
90
83
E85.4
ICD-10 Finland
Organ-limited amyloidosis
+∞
47.7
45
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.3
45.9
95
111
A11CC03
ATC
alfacalcidol; systemic
30.7
45.0
60
22
C90.0
ICD-10 Finland
Multiple myeloma
34.3
44.7
58
19
N08.4
ICD-10 Finland
Glomerular disorders in other endocrine, nutritional and metabolic diseases
+∞
44.4
42
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
47.0
38.9
47
11
A12AA04
ATC
calcium carbonate; oral
36.8
37.0
47
14
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
8.1
36.8
87
126
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
36.3
304
1577
TK800
NOMESCO Finland
Hemodialysis
18.8
33.1
51
30
2773B
ICD-9 Finland
Other and unspecified disorders of metabolism, Amyloidosis[AMYLOIDOSIS SECUNDARIA]
+∞
31.6
30
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
36.0
31.4
40
12
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
26.8
30.6
42
17
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
22.8
30.6
44
21
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
35.1
30.5
39
12
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
18.4
30.3
47
28
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
33.1
28.5
37
12
E85.0
ICD-10 Finland
Non-neuropathic heredofamilial amyloidosis
+∞
28.4
27
*
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
106.1
28.0
30
*
N18.0
ICD-10 Finland
End-stage renal disease
34.0
27.2
35
11
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
27.1
116
336
153
Kela drug reimbursment
Lenalidomid
44.0
27.1
33
8
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
102.3
26.9
29
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.2
26.6
111
314
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
5.9
26.5
78
151
M04AA01
ATC
allopurinol; systemic
3.8
26.1
124
394
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
26.7
25.6
35
14
I50.9
ICD-10 Finland
Heart failure, unspecified
3.6
25.4
130
439
I43.1
ICD-10 Finland
Cardiomyopathy in metabolic diseases
+∞
25.2
24
*
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
+∞
25.2
24
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
7.7
25.1
60
87
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.2
25.0
164
667
N18.8
ICD-10 Finland
Other chronic renal failure
11.4
24.9
47
45
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.2
24.7
45
40
B03XA01
ATC
erythropoietin; parenteral
36.6
24.6
31
9
137
Kela drug reimbursment
Uraemia requiring dialysis
51.1
24.5
29
6
Z49.0
ICD-10 Finland
Preparatory care for dialysis
91.2
23.9
26
*
H16.0
ICD-10 Finland
Corneal ulcer
7.6
23.4
56
81
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
22.7
130
472
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.2
22.6
142
553
N19
ICD-10 Finland
Unspecified kidney failure
8.8
22.5
49
61
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
17.0
22.2
35
22
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
65.6
22.0
25
*
H19.8
ICD-10 Finland
Other disorders of sclera and cornea in diseases classified elsewhere
+∞
22.0
21
*
B03XA02
ATC
darbepoetin alfa; parenteral
15.4
22.0
36
25
V03AE01
ATC
polystyrene sulfonate; oral
23.5
22.0
31
14
L01AA03
ATC
melphalan; systemic
120.2
21.7
23
*
L04AA01
ATC
[U] ciclosporin; systemic
15.6
21.5
35
24
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
21.3
117
411
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
21.1
222
1183
L04AX04
ATC
lenalidomide; oral
34.1
20.4
26
8
C03DA01
ATC
spironolactone; oral
3.8
19.9
93
286
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
8.8
19.9
43
53
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
19.8
90
271
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
7.5
19.7
47
68
WW300
NOMESCO Finland
Transfer of autologic stem cells
41.9
19.7
24
6
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.7
19.5
70
168
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
23.7
19.3
27
12
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
7.1
19.3
48
74
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
57.3
19.1
22
*
L99.0*E85.9
ICD-10 Finland
Amyloidosis of skin
+∞
18.9
18
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
10.7
18.7
36
36
Z94.0
ICD-10 Finland
Kidney transplant status
31.4
18.5
24
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
18.4
75
204
L04AA06
ATC
mycophenolic acid; systemic
20.3
18.4
27
14
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
45.8
18.4
22
5
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.5
18.3
93
306
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
14.4
18.0
30
22
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.7
17.9
63
148
E85.8
ICD-10 Finland
Other amyloidosis
+∞
17.8
17
*
AA1AA
NOMESCO Finland
Head X-ray examination
38.2
17.7
22
6
B05DA
ATC
Isotonic solutions
98.5
17.7
19
*
J01MA12
ATC
levofloxacin; systemic
2.8
17.7
131
556
H02AB02
ATC
dexamethasone; systemic
3.4
17.6
91
303
AA1AD
NOMESCO Finland
CT of head and brain
2.6
17.4
154
728
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.8
17.2
78
233
ZXA05
NOMESCO Finland
Left side
2.5
17.2
167
830
WX002
NOMESCO Finland
Sedation and analgesia
2.7
17.1
134
588
329
Kela drug reimbursment
Lenalidomide
51.9
17.1
20
*
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
51.9
17.1
20
*
I50.0
ICD-10 Finland
Congestive heart failure
4.0
17.0
72
202
N17.9
ICD-10 Finland
Acute renal failure, unspecified
6.8
17.0
43
68
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
8.5
16.6
36
45
127
Kela drug reimbursment
Transplant complication
16.4
15.9
25
16
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
7.0
15.7
39
60
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
15.7
182
980
Z49.2
ICD-10 Finland
Other dialysis
164.8
15.6
16
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
39.4
15.5
19
5
J05AB01
ATC
aciclovir; systemic
2.6
15.3
131
602
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.1
15.2
61
163
A04AA01
ATC
ondansetron; systemic, rectal
4.3
15.2
58
148
R06.0
ICD-10 Finland
Dyspnoea
2.4
15.0
155
788
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
58.5
14.9
17
*
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
19.1
14.8
22
12
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.7
14.7
34
47
V03AE02
ATC
sevelamer; oral
82.5
14.6
16
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
82.5
14.6
16
*
L04AX01
ATC
azathioprine; systemic
5.3
14.6
45
92
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
28.1
14.4
19
7
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.2
14.3
56
146
R80
ICD-10 Finland
Isolated proteinuria
19.8
14.3
21
11
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
14.2
125
579
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.3
14.0
73
243
C07AB07
ATC
bisoprolol; oral
2.1
13.8
269
1798
CG2T4
NOMESCO Finland
Topography assessment of cornea
15.3
13.7
22
15
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.1
13.7
33
49
H02.2
ICD-10 Finland
Lagophthalmos
35.1
13.6
17
5
B05DB
ATC
Hypertonic solutions
143.6
13.5
14
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
143.6
13.5
14
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
13.4
242
1560
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.0
13.3
55
151
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.1
13.3
205
1237
ZX120
NOMESCO Finland
Intravenous
3.2
13.1
73
254
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
8.0
13.1
29
38
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
29.2
13.0
17
6
XF404
NOMESCO Finland
Ambulatory ECG
3.1
13.0
75
268
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.9
12.9
85
331
CG2S4
NOMESCO Finland
Photography of cornea
51.4
12.9
15
*
CBJ50
NOMESCO Finland
Operation for ptosis of eyebrow
14.5
12.9
21
15
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
32.9
12.6
16
5
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.0
12.5
76
281
ZX108
NOMESCO Finland
Inhalation
20.7
12.5
18
9
ZXA00
NOMESCO Finland
Right side
2.2
12.5
169
956
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.7
12.4
56
166
QAJ10
NOMESCO Finland
Browlift
38.5
12.3
15
*
9272
FHL
Metatarsophalangeal joint resection
38.5
12.3
15
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.3
12.1
129
655
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.4
12.1
59
187
H02AB06
ATC
prednisolone; systemic
2.0
12.0
253
1708
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
47.8
11.9
14
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
11.8
169
977
B01AB05
ATC
enoxaparin; parenteral
2.1
11.7
172
1004
L01AA01
ATC
cyclophosphamide; systemic
66.5
11.7
13
*
L04AA13
ATC
leflunomide; oral
7.0
11.6
28
42
QAJ20
NOMESCO Finland
Subperiosteal facelift
+∞
11.5
11
*
2773A
ICD-9 Finland
Other and unspecified disorders of metabolism, Amyloidosis[AMYLOIDOSIS PRIMARIA]
+∞
11.5
11
*
N08.4*E85.80
ICD-10 Finland
Glomerular disease in Meretoja's patients
+∞
11.5
11
*
1XX32
NOMESCO Finland
NA
122.6
11.5
12
*
C10AA05
ATC
atorvastatin; oral
2.0
11.4
205
1297
H04.10
ICD-10 Finland
Dry eye syndrome
3.1
11.4
66
237
R4120
NOMESCO Finland
Occupational therapy
3.7
11.3
50
146
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.4
11.1
55
176
ZXA10
NOMESCO Finland
Bilateral
2.3
11.1
119
603
H02.4
ICD-10 Finland
Ptosis of eyelid
5.5
11.1
32
61
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
7.2
11.0
26
38
A46
ICD-10 Finland
Erysipelas
2.6
11.0
87
378
TK810
NOMESCO Finland
Hemofiltration
44.3
11.0
13
*
ZX112
NOMESCO Finland
Subcutaneous
6.7
10.9
27
42
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.6
10.9
88
383
A07AA09
ATC
vancomycin; oral
10.9
10.9
20
19
C09AA05
ATC
ramipril; oral
2.1
10.8
151
858
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
18.3
10.8
16
9
E87.5
ICD-10 Finland
Hyperkalaemia
28.7
10.8
14
5
9283
FHL
Subtalar joint ossification surgery (or triple)
28.7
10.8
14
5
WX892
NOMESCO Finland
Monitored bed care
3.2
10.6
56
188
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.0
10.5
42
113
YNB10
NOMESCO Finland
Collection of stem cells for transplant
112.2
10.5
11
*
TK820
NOMESCO Finland
Peritoneal dialysis
+∞
10.4
10
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
+∞
10.4
10
*
E85
ICD-10 Finland
Amyloidosis
+∞
10.4
10
*
L01CB
ATC
Podophyllotoxin derivatives
+∞
10.4
10
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
10.4
142
797
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
10.3
57
196
WW200
NOMESCO Finland
Immunization
5.7
10.1
28
51
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
10.0
73
302
QAJ30
NOMESCO Finland
Other facelift
40.9
10.0
12
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
40.9
10.0
12
*
B01AB10
ATC
tinzaparin; parenteral
3.3
10.0
50
162
A07EC01
ATC
sulfasalazine; oral, rectal
3.1
9.9
55
189
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.5
9.9
17
14
H02.1
ICD-10 Finland
Ectropion of eyelid
9.0
9.9
20
23
TFJ02
NOMESCO Finland
Muscle biopsy of heart
26.6
9.9
13
5
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.9
9.8
31
66
ACC51
NOMESCO Finland
Release of median nerve
3.3
9.7
50
165
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.3
9.7
48
154
S01XA18
ATC
ciclosporin; ophthalmic
56.1
9.7
11
*
R50.9
ICD-10 Finland
Fever, unspecified
2.4
9.6
84
383
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.0
9.6
55
195
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
5.0
9.6
30
63
3AC01
NOMESCO Finland
NA
15.4
9.6
15
10
B01AC04
ATC
clopidogrel; oral
2.4
9.5
88
413
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
101.8
9.4
10
*
ZZC00
NOMESCO Finland
Graft of fascia
+∞
9.4
9
*
E85.2
ICD-10 Finland
Heredofamilial amyloidosis, unspecified
+∞
9.4
9
*
27699
ICD-8 Finland
Amyloidosis
+∞
9.4
9
*
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
22.2
9.4
13
6
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.8
9.3
61
235
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
9.2
37
100
L04AD01
ATC
ciclosporin; systemic
6.5
9.2
23
37
Z31.5
ICD-10 Finland
Genetic counselling
4.4
9.2
32
76
CBB20
NOMESCO Finland
Correction of lax skin of eyelid and resection of herniated fat
8.5
9.1
19
23
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.5
9.1
75
331
9294
FHL
Endoprosthesis replacement of the entire hip joint (eg Charnley)
10.3
9.1
17
17
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
37.4
9.0
11
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
9.0
304
2316
R4110
NOMESCO Finland
Physiotherapy
2.0
9.0
142
838
R60.0
ICD-10 Finland
Localized oedema
2.5
9.0
72
314
XCK10
NOMESCO Finland
Photography of fundus of eye
2.6
9.0
66
274
NCB20
NOMESCO Finland
Primary total prosthetic replacement of elbow joint
24.5
8.9
12
5
9256
FHL
Synovectomy (knee 9311)
24.5
8.9
12
5
E83.50
ICD-10 Finland
Hypercalcemia
24.5
8.9
12
5
L01AA02
ATC
chlorambucil; oral
24.5
8.9
12
5
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
8.2
8.9
19
24
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.3
8.9
26
51
G51.0
ICD-10 Finland
Bell palsy
5.8
8.8
24
43
H02.3
ICD-10 Finland
Blepharochalasis
2.9
8.8
54
198
N02AX02
ATC
tramadol; systemic, rectal
1.8
8.7
221
1531
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
6.8
8.7
21
32
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
50.9
8.7
10
*
L28
ICPC
Limited function/disability (L)
2.2
8.7
97
496
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.0
8.6
49
173
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
3.1
8.6
48
167
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
28.0
8.5
11
*
CBF99
NOMESCO Finland
Other operation for ectropion
28.0
8.5
11
*
E86
ICD-10 Finland
Volume depletion
28.0
8.5
11
*
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
91.5
8.4
9
*
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
91.5
8.4
9
*
M01CB01
ATC
sodium aurothiomalate; parenteral
8.1
8.4
18
23
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
8.4
60
246
7143C
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]
+∞
8.4
8
*
V03AE03
ATC
lanthanum carbonate; oral
+∞
8.4
8
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
6.7
8.3
20
31
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
14.8
8.2
13
9
212
Kela drug reimbursment
Gout
6.2
8.2
21
35
C08CA01
ATC
amlodipine; oral
1.8
8.2
195
1322
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
12.0
8.1
14
12
9314
FHL
Total knee endoprosthesis (also includes patellar part)
17.5
8.1
12
7
L04AA11
ATC
[U] etanercept; parenteral
33.9
8.1
10
*
K65.0
ICD-10 Finland
Acute peritonitis
10.3
8.1
15
15
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.6
8.1
35
102
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.2
8.1
89
451
J01DA01
ATC
[U] cefalexin; systemic
1.7
8.0
303
2352
WX110
NOMESCO Finland
Local anesthesy
1.7
8.0
312
2444
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
8.7
7.9
16
19
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.9
7.9
46
167
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
11.0
7.8
14
13
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
3.4
7.8
37
116
9289
FHL
Other measure in this category
45.7
7.7
9
*
9284
FHL
Wrist ossification surgery
45.7
7.7
9
*
H02AB04
ATC
methylprednisolone; systemic
2.2
7.7
81
403
S97
ICPC
Chronic ulcer skin
3.2
7.7
40
134
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.9
7.7
46
170
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.9
7.6
18
27
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
25.4
7.6
10
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
3.1
7.6
40
136
I42.5
ICD-10 Finland
Other restrictive cardiomyopathy
81.2
7.4
8
*
CBH25
NOMESCO Finland
Tarsorrhaphy
81.2
7.4
8
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
81.2
7.4
8
*
L88
ICPC
Rheumatoid/seropositive arthritis
3.8
7.4
30
83
XF402
NOMESCO Finland
ECG with work load test
2.3
7.4
67
310
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
3.4
7.3
34
105
RD210
NOMESCO Finland
NA
9.6
7.3
14
15
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
7.3
88
463
H25.1
ICD-10 Finland
Senile nuclear cataract
1.8
7.3
158
1030
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
7.3
97
531
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
16.0
7.3
11
7
H26.3
ICD-10 Finland
Drug-induced cataract
16.0
7.3
11
7
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
7.2
49
193
S18
ICPC
Laceration/cut
1.7
7.2
219
1580
A02BC02
ATC
pantoprazole; systemic
1.7
7.2
317
2533
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
30.5
7.2
9
*
H02AB07
ATC
prednisone; oral
2.1
7.2
81
415
D06BB04
ATC
podophyllotoxin; topical
4.6
7.0
23
52
B01AA03
ATC
warfarin; systemic
1.9
7.0
122
740
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
7.0
80
414
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
7.0
93
510
E000001
ATC
NA
2.0
7.0
100
563
C09CA01
ATC
losartan; oral
1.8
7.0
131
816
H16.9
ICD-10 Finland
Keratitis, unspecified
7.7
6.9
15
20
L04AB01
ATC
etanercept; parenteral
7.7
6.9
15
20
TQW40
NOMESCO Finland
Remowal of suture of skin
2.8
6.9
44
168
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
6.8
101
578
TQW99
NOMESCO Finland
Other minor procedure on skin
2.9
6.8
39
140
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
40.6
6.8
8
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
6.8
114
683
B01AB04
ATC
dalteparin; parenteral
3.1
6.8
35
118
N05CF01
ATC
zopiclone; oral
1.7
6.8
170
1157
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
6.7
88
480
WX320
NOMESCO Finland
Spinalanesthesy
1.9
6.7
115
692
E0000UV
ATC
NA
1.7
6.7
181
1253
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
22.8
6.7
9
*
WW409
NOMESCO Finland
Other aferesis
22.8
6.7
9
*
L04AC07
ATC
tocilizumab; parenteral
22.8
6.7
9
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
6.7
72
363
RS221
NOMESCO Finland
NA
6.0
6.7
17
29
ZZH31
NOMESCO Finland
Bone allograft, small pieces
8.0
6.6
14
18
H18.4
ICD-10 Finland
Corneal degeneration
12.5
6.6
11
9
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
12.5
6.6
11
9
XX9XE
NOMESCO Finland
Other ultrasound examination
8.9
6.6
13
15
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
8.9
6.6
13
15
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
4.3
6.6
23
56
C09CA06
ATC
candesartan; oral
1.9
6.6
109
647
J01FF01
ATC
clindamycin; systemic
1.8
6.5
132
840
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.3
6.5
16
26
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
6.5
41
155
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.9
6.5
25
67
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
70.7
6.4
7
*
NDG77
NOMESCO Finland
Other excision, reconstruction or fusion of joint of first finger
70.7
6.4
7
*
QAJ15
NOMESCO Finland
Browlift using video-endoscope
70.7
6.4
7
*
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
70.7
6.4
7
*
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.5
6.4
21
48
NHG20
NOMESCO Finland
Fusion of talocrural joint
14.5
6.4
10
7
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.2
6.4
66
327
H02AB09
ATC
hydrocortisone; systemic
5.6
6.3
17
31
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
11.2
6.3
11
10
CBN30
NOMESCO Finland
Shortening of canthal ligament
11.2
6.3
11
10
L03AA02
ATC
filgrastim; parenteral
4.2
6.3
22
54
L99.0
ICD-10 Finland
Amyloidosis of skin
+∞
6.3
6
*
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
+∞
6.3
6
*
QAJ35
NOMESCO Finland
Other correction of loose or redundant skin of head or neck
+∞
6.3
6
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
3.2
6.2
31
102
C02AC05
ATC
moxonidine; oral
3.2
6.2
31
102
M05BA04
ATC
alendronic acid; oral
2.3
6.2
57
264
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.4
6.2
15
24
P01BA02
ATC
hydroxychloroquine; oral
2.4
6.2
50
221
NF1AA
NOMESCO Finland
Hip X-ray examination
2.3
6.1
54
248
L04AB04
ATC
adalimumab; parenteral
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494890) Protein electrophoresis panel - 24 hour Urine
138
39
46.05
226.63
4.7
2.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
195
162
17.58
206.24
13.0
3.3
ratio
1.8
2.2
0.14
12
16
(3034860) Kappa light chains.free [Mass/volume] in Serum
197
167
17.31
205.93
13.2
3.3
mg/l
70.1
81.8
0.10
171
137
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
197
167
17.31
205.93
13.2
3.3
mg/l
66.3
52.9
0.29
170
140
(40760888) Immunoglobulin light chains.free panel - Serum
169
120
19.42
194.16
12.0
3.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
95
14
80.87
177.02
3.1
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
155
114
18.16
173.97
3.0
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
232
357
10.13
157.08
8.1
2.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
245
424
9.24
149.46
8.5
2.5
g/l
62.8
66.3
6.35
235
385
(3017817) Protein [Mass] in Urine collected for unspecified duration
84
41
23.77
113.01
4.2
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
233
539
6.53
103.38
12.4
4.7
mmol/l
1.1
1.0
7.28
225
491
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
141
197
9.12
100.31
8.5
2.1
g/l
7.2
7.3
0.20
110
149
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
197
9.04
98.95
8.6
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
197
9.04
98.95
8.5
2.1
g/l
3.3
3.7
2.07
104
145
(3020779) Urea [Moles/volume] in Serum or Plasma
187
365
7.07
98.21
13.0
6.0
mmol/l
13.2
10.6
3.73
178
342
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
135
186
9.14
97.00
8.8
2.2
g/l
2.9
3.2
1.77
106
148
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
134
185
9.11
96.07
8.5
2.2
g/l
8.7
10.8
3.13
111
157
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
127
169
9.33
93.72
8.6
2.3
g/l
1.6
1.5
0.11
113
145
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
210
532
5.61
82.18
6.3
4.5
u/l
247.2
245.0
0.11
205
505
(3005719) IgG [Mass/volume] in Serum or Plasma
162
329
6.43
80.52
4.7
2.6
g/l
9.1
11.1
3.77
154
303
(3028026) IgM [Mass/volume] in Serum or Plasma
140
257
6.85
76.81
4.3
1.6
g/l
1.3
1.6
0.35
130
234
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
107
151
8.45
74.54
8.4
2.2
g/l
0.0
0.0
0.76
102
137
(3023520) Reticulocytes [#/volume] in Blood
175
413
5.63
73.44
2.6
2.9
e9/l
66.5
68.7
0.34
141
321
(3042111) Morphology [Interpretation] in Bone marrow Narrative
82
85
11.06
72.40
1.3
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
202
552
5.07
71.16
3.0
2.6
%
1.7
1.8
0.24
189
499
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
107
160
7.97
70.78
8.3
2.1
g/l
36.0
37.2
0.91
99
137
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
100
142
8.29
69.12
8.8
2.3
g/l
0.0
0.0
0.00
95
130
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
100
145
8.12
67.84
8.8
2.2
g/l
0.0
0.0
0.50
95
131
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
147
351
5.26
59.93
5.9
3.0
ng/l
126.1
84.7
1.02
129
303
(3045142) Bone marrow Pathology biopsy report
60
53
12.50
58.67
1.2
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
197
624
4.26
55.80
4.9
2.2
%
20.5
22.7
1.53
178
541
(3017704) Immunofixation for Urine
48
33
15.76
54.22
3.4
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
199
664
4.03
51.98
5.5
3.2
mmol/l
0.8
0.8
0.42
191
621
(3018677) aPTT in Platelet poor plasma by Coagulation assay
200
676
3.98
51.19
3.3
1.8
s
29.7
29.8
0.03
194
650
(3022948) Iron [Moles/volume] in Serum or Plasma
207
727
3.86
49.96
4.8
2.2
umol/l
10.7
12.9
4.85
202
672
(42870588) Differential panel, method unspecified - Blood
318
1504
3.45
47.72
10.0
5.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
33
13
26.85
47.40
1.2
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
314
1520
3.31
44.47
8.5
3.0
ng/l
3827.9
1430.4
7.24
296
1297
(46235355) HIV 1 and 2 tests - Meaningful Use set
155
480
4.04
44.26
2.0
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
139
400
4.25
43.88
2.0
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
377
2057
3.36
43.17
11.4
4.3
g/l
32.2
35.2
14.26
360
1892
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
389
2185
3.34
41.94
15.2
5.1
mmol/l
1.2
1.2
0.91
367
1952
(3026493) Urate [Moles/volume] in Serum or Plasma
262
1176
3.23
41.51
6.1
2.6
umol/l
385.6
7972.4
4.94
242
989
(3006315) Basophils [#/volume] in Blood
394
2238
3.35
41.51
11.6
5.4
e9/l
0.0
0.0
0.03
363
1927
(3017143) Hepatitis C virus Ab [Presence] in Serum
129
365
4.25
41.50
2.0
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
401
2305
3.37
41.33
11.8
5.5
e9/l
0.2
0.2
2.44
367
2018
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
98
224
5.06
41.22
1.9
1.9
g/l
1.5
1.6
0.25
88
194
(3001604) Monocytes [#/volume] in Blood
392
2226
3.32
41.19
11.5
5.3
e9/l
0.6
0.6
1.90
360
1907
(3019198) Lymphocytes [#/volume] in Blood
396
2269
3.32
40.84
11.6
5.4
e9/l
1.7
1.9
2.36
365
1996
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
408
2387
3.36
40.44
19.5
5.8
mmol/l
1.2
1.2
1.25
349
2020
(3022096) Basophils/100 leukocytes in Blood
368
2041
3.18
39.75
11.6
5.5
%
0.7
0.7
0.20
352
1891
(3019069) Monocytes/100 leukocytes in Blood
376
2114
3.19
39.59
12.0
5.7
%
9.0
8.8
0.51
360
1965
(3006504) Eosinophils/100 leukocytes in Blood
373
2101
3.15
38.88
11.6
5.5
%
2.6
2.9
2.50
357
1941
(3002030) Lymphocytes/100 leukocytes in Blood
377
2143
3.15
38.54
11.8
5.6
%
24.3
27.1
4.77
361
1972
(3018418) pH of Serum or Plasma
286
1414
3.01
37.28
13.5
3.5
ph
7.4
7.4
0.26
63
273
(3018010) Neutrophils/100 leukocytes in Blood
371
2115
3.07
37.25
11.3
5.4
%
61.0
57.7
5.45
353
1966
(3007164) IgA [Mass/volume] in Serum or Plasma
186
766
3.10
32.92
3.6
1.3
g/l
2.1
2.7
1.85
143
440
(3021879) Hepatitis B virus core Ab [Presence] in Serum
95
253
4.29
32.73
1.6
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
188
788
3.05
32.16
2.4
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
267
1356
2.79
31.85
6.9
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
411
2605
2.96
31.74
18.5
8.8
e9/l
4.4
4.0
2.86
377
2287
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
144
5.13
29.99
3.6
2.5
u/ml
0.3
0.3
0.30
40
80
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
266
1385
2.69
29.71
3.1
2.0
u/l
173.9
255.5
0.74
250
1300
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
51
88
6.26
28.85
4.5
4.9
iu/ml
1200.0
221.2
0.52
12
13
(40768446) Kidney Pathology biopsy report
34
7
51.41
28.71
1.1
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
72
171
4.66
28.59
3.5
2.9
g/l
0.7
0.3
2.39
45
68
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
307
1739
2.62
28.54
5.2
3.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
38
49
8.23
27.96
1.2
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
118
414
3.32
26.88
5.4
2.9
ng/l
471.1
219.8
3.26
111
384
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
100
319
3.58
26.44
2.3
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
112
393
3.29
25.42
7.3
3.0
kpa
6.0
5.9
0.83
112
379
(3002032) Base excess in Venous blood by calculation
111
391
3.27
25.01
7.3
3.0
mmol/l
2.0
2.4
0.45
96
308
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
71
185
4.23
24.97
7.6
3.2
mmol/l
24.2
24.5
0.30
66
163
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
49
94
5.60
24.80
1.4
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
104
354
3.36
24.76
9.5
7.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
305
1821
2.42
23.99
4.6
2.5
ug/l
191.7
149.2
2.47
285
1644
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
305
1837
2.38
23.30
8.0
3.4
ng/l
65.0
50.1
0.35
268
1364
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
133
543
2.88
23.03
2.3
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
257
1442
2.40
23.01
5.1
3.1
e6/l
34.1
126.9
1.21
226
1135
(3030467) Casts [#/volume] in Urine by Automated count
243
1331
2.42
22.97
4.9
3.0
e6/l
0.4
0.5
0.26
212
1021
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
225
1195
2.44
22.74
2.6
2.1
mg/l
3.0
3.3
1.03
200
1007
(3026782) Osmolality of Urine
188
922
2.53
22.56
4.0
2.7
mosm/kgh2o
490.7
556.8
5.37
164
777
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
86
277
3.47
22.24
6.0
3.4
mmol/l
1.1
2.0
1.67
65
216
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
184
900
2.53
22.15
9.5
3.5
ng/l
251.0
313.9
0.24
175
727
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
41
74
5.88
22.10
1.7
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
398
2730
2.44
22.08
9.1
4.4
mmol/l
6.6
6.7
0.17
384
2553
(3048879) Bone marrow aspiration report
21
16
13.58
22.07
2.0
2.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
38
64
6.28
21.95
1.9
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
249
1401
2.36
21.90
6.0
3.0
mg/l
2689.1
358.1
3.28
192
873
(3036489) Thrombin time
56
135
4.48
21.71
2.7
1.9
s
22.6
21.4
1.17
48
124
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
130
541
2.81
21.61
2.2
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
280
1666
2.31
21.49
5.9
3.5
e6/l
74.0
145.9
0.86
232
1219
(36304419) Bacteria [Presence] in Urine
232
1277
2.36
21.34
4.8
3.0
—
—
—
0
0
(3009343) pH of Capillary blood
88
296
3.32
21.22
6.1
3.3
ph
7.4
7.4
0.08
14
32
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
366
2445
2.34
21.21
9.7
6.2
umol/l
11.1
11.8
0.83
357
2322
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
34
54
6.62
20.77
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
88
302
3.25
20.51
6.1
3.3
kpa
4.9
5.2
2.75
83
279
(3007853) Bacteria identified in Skin by Aerobe culture
127
536
2.75
20.46
2.2
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
40
77
5.50
20.13
1.7
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
248
1432
2.27
20.11
4.6
2.9
mmol/l
5.8
7.4
9.90
221
1173
(4035726)
106
411
2.93
19.99
1.4
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
314
2004
2.23
19.82
12.6
9.5
inr
1.3
1.3
0.02
84
558
(3042936) Bacteria identified in Isolate by Culture
149
692
2.55
19.73
3.0
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
181
922
2.40
19.59
2.1
1.6
mg/l
1.8
1.4
0.39
141
705
(1616796) Gas panel - Central venous blood
42
87
5.12
19.49
6.5
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
51
125
4.38
19.34
1.4
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
268
1621
2.21
19.15
4.8
3.3
mmol/l
2.3
2.4
2.90
233
1378
(40758558) Short blood count panel - Blood
202
1090
2.31
19.05
13.0
6.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
251
1484
2.21
18.93
5.6
3.7
mg/mmol
75.7
6.6
7.74
191
904
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
50
123
4.35
18.86
2.0
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
30
47
6.68
18.54
1.5
1.1
mmol/l
48.2
65.7
1.86
22
37
(3037522) Nuclear Ab [Titer] in Serum
127
568
2.58
18.05
1.3
1.3
titre
597.0
472.3
0.37
27
130
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
84
302
3.08
18.02
2.0
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
191
1029
2.27
17.90
3.8
2.4
e6/l
3.6
5.2
2.13
178
907
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
47
118
4.24
17.26
2.0
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
38
83
4.83
16.57
1.6
1.4
g/l
23.9
32.5
3.43
30
73
(3012441) Differential panel - Pleural fluid
32
60
5.58
16.54
1.4
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
426
3195
2.24
16.49
7.3
4.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
148
746
2.32
16.00
4.2
2.9
e6/l
3.8
2.0
1.06
97
417
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
112
498
2.55
15.98
3.5
2.7
umol/l
7.4
8.9
0.54
102
437
(3017181) Myelocytes/100 leukocytes in Blood
98
409
2.68
15.89
5.1
4.2
%
1.2
0.8
0.40
48
130
(3002179) Metamyelocytes/100 leukocytes in Blood
91
366
2.76
15.86
4.6
4.2
%
0.4
0.4
0.00
38
94
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
283
1842
2.04
15.77
3.1
2.1
nmol/l
76.3
78.9
0.87
266
1601
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
27
45
6.24
15.72
3.4
2.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
95
395
2.68
15.50
7.0
6.5
mmol/l
1.2
1.4
1.17
90
377
(40758292) HTLV I+II Ab panel - Serum
14
10
14.32
15.09
1.7
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
38
90
4.45
15.02
1.6
2.6
umol/l
37.5
33.3
0.23
31
74
(3000494) Fungus identified in Specimen by Culture
115
535
2.43
14.82
1.6
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
30
59
5.31
14.73
1.1
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
458
3611
2.25
14.56
16.9
7.2
u/l
83.8
78.7
1.40
443
3349
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
32
7.11
14.51
1.1
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
56
181
3.32
14.27
1.4
1.9
u/l
39.7
38.6
0.13
44
159
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
32
69
4.85
14.16
1.6
1.4
u/ml
117.0
101.8
—
5
8
(3013707) Erythrocyte sedimentation rate by Westergren method
441
3448
2.15
13.97
7.4
4.1
mm/h
19.9
13.3
9.26
415
3143
(3023199) Leukocytes [#/volume] in Pleural fluid
32
70
4.78
13.92
1.4
1.3
e6/l
688.8
1199.1
0.87
22
50
(3021440) Promyelocytes/100 leukocytes in Blood
90
384
2.59
13.88
5.3
4.4
%
0.1
0.1
0.23
45
117
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
47
138
3.62
13.88
1.7
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
30
63
4.97
13.69
1.5
1.4
e6/l
54984.8
120623.1
0.30
13
39
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
35
84
4.37
13.60
1.1
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
230
1448
1.97
13.55
3.5
3.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
150
814
2.13
13.26
4.0
2.7
e6/l
1.2
1.2
0.01
98
484
(3036481) Cortisol [Moles/volume] in Serum or Plasma
84
357
2.58
13.03
2.3
1.9
nmol/l
370.2
372.9
0.04
79
327
(3021589) Normoblasts [#/volume] in Blood
289
1987
1.90
12.89
20.6
9.4
e9/l
0.0
0.0
0.01
246
1624
(3004809) Band form neutrophils/100 leukocytes in Blood
33
79
4.37
12.87
2.8
4.5
%
0.8
0.7
0.11
28
67
(3045788) Cell count panel - Pleural fluid
27
55
5.10
12.75
1.6
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
61
4.77
12.24
6.7
2.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
224
1436
1.91
12.22
3.8
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
168
981
2.00
12.03
2.0
1.7
nmol/l
1051.7
1174.0
0.86
136
725
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
85
4.06
11.71
2.1
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
29
69
4.37
11.40
1.4
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
81
360
2.45
11.40
5.4
4.4
%
0.0
1.0
0.55
40
98
(3012501) Base excess in Blood by calculation
34
92
3.86
11.28
5.9
3.8
mmol/l
2.2
2.8
0.48
25
60
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
19
31
6.30
11.26
1.0
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
137
3.31
11.20
1.3
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
79
4.09
11.16
4.8
3.0
%
58.0
58.3
0.04
31
79
(3003396) Base excess in Arterial blood by calculation
107
546
2.18
10.89
8.3
7.0
mmol/l
0.4
1.5
1.70
83
401
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
107
547
2.17
10.84
8.3
7.0
kpa
4.7
5.1
4.79
100
517
(40767503) Oxygen content in Capillary blood by calculation
33
90
3.83
10.83
5.4
2.3
%
14.9
15.6
0.30
18
41
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
100
500
2.21
10.70
5.4
3.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
33
91
3.78
10.67
2.2
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
101
3.62
10.60
1.5
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
178
1102
1.89
10.52
3.9
2.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
12
12
10.19
10.47
1.2
3.0
%
129.8
91.8
2.35
12
12
(3027801) Oxygen [Partial pressure] in Arterial blood
106
548
2.14
10.41
8.4
7.0
kpa
12.2
11.8
0.28
98
518
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
206
1340
1.83
10.38
4.5
3.1
u/l
32.5
32.4
0.01
196
1261
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
25
57
4.54
10.36
2.0
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
27
6.46
10.32
1.5
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
17
27
6.46
10.32
1.5
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
193
1233
1.85
10.29
2.0
1.5
nmol/l
20.9
21.0
0.03
170
1022
(3030905) Polymorphonuclear cells [#/volume] in Blood
29
75
4.02
10.24
4.9
2.7
e9/l
4.3
4.5
0.14
29
75
(3022313) Gas panel - Capillary blood
57
225
2.70
10.21
6.1
3.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
24
54
4.59
10.10
2.1
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
87
423
2.24
9.93
2.7
2.3
ug/l
5.2
6.8
0.76
73
379
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
26
6.30
9.50
2.5
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
26
6.30
9.50
2.5
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
26
6.30
9.50
2.5
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
26
6.30
9.50
2.5
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
18
33
5.60
9.50
1.7
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
28
75
3.87
9.43
1.6
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
30
5.81
9.32
3.7
2.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
81
3.72
9.22
1.6
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
290
2135
1.71
9.21
5.8
4.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
77
373
2.23
8.85
3.2
2.7
ml/min/173m2
40.4
61.5
5.51
43
136
(3011397) Hemoglobin [Presence] in Urine by Test strip
162
1023
1.81
8.75
4.6
3.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
154
958
1.83
8.74
8.7
4.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
298
2232
1.69
8.70
5.1
3.7
estimate
0.0
0.0
0.00
67
437
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
277
2037
1.69
8.66
2.6
2.0
pmol/l
92.3
96.0
0.60
157
1049
(3022217) INR in Platelet poor plasma by Coagulation assay
115
655
1.94
8.56
22.6
26.1
inr
1.4
1.3
0.03
13
99
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
62
3.99
8.50
2.6
4.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
19
6.98
8.47
2.6
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
19
6.98
8.47
2.6
2.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
28
81
3.58
8.47
5.4
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
296
2225
1.67
8.43
6.9
5.0
estimate
0.0
0.0
0.00
72
436
(3019832) Treponema pallidum Ab [Presence] in Serum
44
168
2.75
8.40
1.7
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
22
54
4.19
8.33
3.1
4.2
%
58.0
50.6
0.69
17
40
(3009261) Glucose [Presence] in Urine by Test strip
299
2260
1.66
8.29
5.2
3.8
estimate
0.0
0.0
0.80
64
430
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
62
284
2.32
8.12
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
55
239
2.44
8.10
12.0
9.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
20
6.63
8.09
2.6
2.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
94
3.31
8.05
1.7
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
28
84
3.45
8.03
1.7
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
17
7.19
8.02
1.3
2.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
16
31
5.28
7.97
1.3
2.1
e9/l
1.1
0.9
—
10
13
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
16
31
5.28
7.97
1.0
1.1
—
75.0
—
0
6
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
35
4.97
7.93
3.1
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
35
4.97
7.93
1.5
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
23
61
3.88
7.87
2.7
1.7
%
89.2
90.2
0.25
23
61
(3006184) Hemoglobin [Mass/volume] in Capillary blood
29
91
3.30
7.77
5.1
2.0
g/l
118.3
125.5
0.80
23
67
(3024928) Oxygen saturation in Venous blood
28
86
3.37
7.75
5.4
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
36
4.83
7.68
1.3
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
205
1432
1.67
7.54
3.2
2.3
u/l
61.7
57.1
0.70
189
1312
(3000475) Leukocytes [#/volume] in Synovial fluid
34
120
2.95
7.50
2.1
1.5
e6/l
19260.9
15118.9
0.21
25
89
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
7
0
+∞
7.30
1.0
0.0
ug/g
174.0
—
—
7
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
76
395
2.06
7.28
2.6
2.6
u/l
46.3
31.7
1.15
64
340
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
7
15.98
7.25
11.5
14.7
mmol/l
4.5
6.5
—
11
7
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
44
182
2.53
7.19
1.9
3.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
24
70
3.53
7.19
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
30
102
3.05
7.06
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
30
102
3.05
7.06
1.2
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
81
3.31
7.05
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
52
3.95
7.03
4.5
3.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
20
52
3.95
7.03
1.6
1.8
g/l
0.6
0.9
0.28
15
41
(40768804) Tissue Pathology biopsy report
251
1870
1.60
7.00
2.5
2.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
48
4.06
6.94
2.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
48
4.06
6.94
2.4
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
48
4.06
6.94
2.4
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
8
13.98
6.91
1.3
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
49
218
2.36
6.86
5.9
2.8
mmol/l
24.5
25.3
0.59
49
211
(3023419) Bacteria identified in Sputum by Culture
22
63
3.59
6.77
1.3
2.1
—
—
—
0
0
(44790048)
22
63
3.59
6.77
1.7
1.3
—
—
—
0
0
(44790047)
22
63
3.59
6.77
1.7
1.3
—
—
—
0
0
(44790049)
22
63
3.59
6.77
1.7
1.3
—
—
—
0
0
(44806118)
22
63
3.59
6.77
1.7
1.3
—
—
—
0
0
(4062490)
14
28
5.10
6.73
1.5
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
37
147
2.62
6.57
4.9
3.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
25
5.30
6.51
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
25
5.30
6.51
1.6
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
46
205
2.35
6.42
2.7
1.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
56
3.66
6.36
1.1
1.2
u/ml
1.8
4.0
—
5
27
(3044941) Cell count panel - Synovial fluid
24
76
3.25
6.36
1.7
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
32
121
2.74
6.26
1.5
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
26
5.09
6.25
1.2
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
30
4.76
6.24
1.3
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
35
139
2.61
6.23
1.7
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
48
222
2.27
6.16
2.2
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
400
3378
1.59
6.13
4.2
3.7
pmol/l
15.1
15.0
0.70
367
3014
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
144
962
1.66
6.10
2.9
3.1
mmol/l
2.5
2.5
3.17
128
834
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
8
12.69
6.10
1.5
2.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
26
91
2.94
5.85
2.7
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
63
335
1.99
5.67
6.3
4.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
17
5.97
5.64
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
42
192
2.28
5.55
2.8
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
52
3.54
5.49
1.7
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
57
3.41
5.48
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
78
3.03
5.47
1.4
1.1
u/ml
221.9
298.8
0.56
17
45
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
107
2.70
5.39
1.2
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
41
188
2.27
5.39
2.1
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
14
34
4.19
5.38
1.5
3.1
%
20.8
40.1
—
5
10
(40768797) Stomach Pathology biopsy report
102
643
1.71
5.33
1.2
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
8
11.40
5.30
1.4
3.4
%
218.1
152.4
—
9
8
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
39
3.92
5.29
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
44
3.71
5.23
1.1
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
501
4539
1.74
5.13
39.1
14.2
mg/l
24.7
26.1
0.45
445
3598
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
6
13.49
5.09
1.3
1.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
6
13.49
5.09
1.3
1.2
%
125.3
87.7
—
8
6
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
28
111
2.60
5.03
1.4
1.2
mg/l
779.3
490.0
1.64
28
101
(4306422)
16
46
3.55
4.92
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
32
4.13
4.92
1.1
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
20
5.07
4.79
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
42
205
2.13
4.77
1.2
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
33
4.01
4.73
1.2
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
387
3336
1.48
4.63
6.5
3.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
462
4134
1.57
4.59
5.2
4.5
mu/l
2.1
2.0
0.81
424
3695
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
25
4.47
4.58
1.7
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
328
2744
1.45
4.56
3.9
3.0
u/l
68.6
50.8
1.78
306
2516
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
21
4.83
4.54
1.2
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
24
93
2.65
4.53
1.3
1.3
e6/l
710.4
1304.4
0.20
18
76
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
24
93
2.65
4.53
1.3
1.2
e6/l
4.6
37.9
0.49
18
72
(3019225) pH of Specimen
83
521
1.69
4.39
11.3
3.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
26
4.29
4.37
1.6
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
12
7.60
4.37
2.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
22
4.61
4.31
2.4
2.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
9
8.99
4.29
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
36
3.67
4.22
1.9
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
79
2.72
4.20
1.1
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
27
4.13
4.18
1.6
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
68
2.85
4.16
1.6
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
70
2.77
3.95
1.8
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
33
3.69
3.94
1.6
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
119
2.33
3.93
1.4
1.5
ug/g
241.0
277.8
0.49
19
76
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
276
2277
1.40
3.93
2.9
2.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
41
214
1.99
3.93
1.6
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
43
3.31
3.93
1.1
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
24
4.22
3.90
1.6
1.7
u/ml
532.6
1656.6
—
10
24
(4027681)
10
24
4.22
3.90
1.5
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
10
24
4.22
3.90
1.9
1.2
u/l
10.2
6.1
—
10
19
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
134
2.23
3.80
1.6
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
12
6.74
3.68
1.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
110
2.33
3.67
1.8
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
30
3.72
3.65
1.2
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
26
3.90
3.53
1.0
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
17
5.36
3.52
5.8
22.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
6
10.09
3.50
1.0
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
12
36
3.38
3.49
1.1
1.0
ng/l
662.0
313.5
1.50
12
20
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
36
3.38
3.49
1.3
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
255
0.34
3.39
1.2
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
13
42
3.14
3.39
1.2
1.3
u/l
13.3
13.4
0.02
13
37
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
27
3.75
3.36
2.4
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
66
2.62
3.24
1.7
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
15
5.39
3.20
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
15
5.39
3.20
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
23
104
2.26
3.20
3.9
2.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
73
2.51
3.15
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
67
2.58
3.15
1.8
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
67
2.58
3.15
1.7
1.3
—
—
—
0
0
(3013512) EKG study
190
1521
1.37
3.07
5.6
3.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
68
2.55
3.06
1.8
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
68
2.55
3.06
1.7
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
16
5.05
3.06
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
437
3979
1.39
3.00
36.9
15.5
%
38.1
39.5
2.46
282
2568
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
5
10.07
2.98
7.4
7.4
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
5
10.07
2.98
1.0
1.0
umol/l
19.8
16.1
—
5
5
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
76
2.41
2.92
1.6
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
18
76
2.41
2.92
2.1
2.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
52
2.73
2.90
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
147
1138
1.39
2.89
1.5
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
22
4.14
2.89
1.1
1.0
nmol/l
116.4
134.4
—
9
22
(3002385) Erythrocyte distribution width [Ratio]
405
3652
1.36
2.88
45.3
17.6
%
14.4
13.8
10.70
399
3564
(3042733) HLA Ab [Presence] in Serum
6
9
6.72
2.87
6.5
4.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
12
41
2.97
2.87
1.1
1.1
g/l
2.0
1.5
1.83
12
35
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
11
36
3.10
2.82
1.1
1.0
ng/l
642.4
590.7
0.11
11
20
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
11
36
3.10
2.82
1.1
1.0
ng/l
45.4
49.6
0.13
11
19
(40761536) Microorganisms panel - Urine sediment
61
399
1.59
2.78
6.8
3.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
42
2.90
2.76
1.1
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
6
8.39
2.75
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
72
2.40
2.75
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
20
4.04
2.57
3.2
1.2
%
9.6
11.1
—
8
20
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
44
2.76
2.56
1.1
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
129
1.98
2.54
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
28
151
1.90
2.51
1.6
1.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
36
211
1.75
2.49
4.6
2.1
%
0.8
0.7
1.56
36
204
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
101
752
1.41
2.48
1.3
1.3
iu/ml
27.2
42.1
0.94
38
239
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
16
4.41
2.48
1.1
1.2
—
—
—
0
0
(4094501)
24
124
1.98
2.44
1.1
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
63
430
1.52
2.40
4.6
3.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
41
253
1.67
2.37
4.1
2.5
e6/l
0.2
0.4
0.66
41
246
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
8
6.29
2.37
1.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
463
4310
1.36
2.35
5.0
3.9
mmol/l
1.3
1.2
2.00
421
3841
(3027456) Digoxin [Moles/volume] in Serum or Plasma
24
129
1.90
2.20
2.0
3.0
nmol/l
1.0
0.9
0.64
12
102
(3048689) Calprotectin [Mass/mass] in Stool
65
457
1.48
2.17
1.7
2.2
ug/g
121.1
137.7
0.25
58
355
(40761511) CBC panel - Blood by Automated count
498
4707
1.40
2.16
32.7
13.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
30
3.03
2.15
1.2
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
10
5.03
2.07
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
7
21
3.36
1.97
1.0
1.0
u/l
32.7
29.5
—
7
14
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
7
21
3.36
1.97
1.0
1.0
u/l
86.3
103.7
—
7
15
(3028433) Virus identified in Specimen by Culture
7
21
3.36
1.97
1.1
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
461
4324
1.32
1.96
6.4
5.8
mmol/mol
39.8
39.8
0.04
429
3935
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
72
527
1.42
1.96
1.3
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
506
4814
1.39
1.94
42.4
16.5
mmol/l
138.9
139.8
9.15
497
4660
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
16
3.78
1.94
5.8
1.8
u/l
216.0
198.3
—
6
16
(3023410) Appearance of Cerebral spinal fluid
9
33
2.75
1.94
1.3
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
507
4829
1.38
1.89
44.4
16.6
mmol/l
4.0
4.0
3.09
495
4672
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
55
390
1.45
1.79
1.8
1.9
%
1.5
1.5
0.14
42
331
(3002256) Pathology report gross observation
81
616
1.37
1.78
1.5
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
92
716
1.34
1.74
1.2
1.3
u/ml
48.2
14.8
0.92
25
270
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
13
3.87
1.72
2.4
2.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
55
2.21
1.68
1.2
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
19
3.18
1.66
1.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
19
3.18
1.66
1.0
1.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
14
69
2.05
1.66
3.2
1.6
mu/l
205.0
256.2
0.68
14
60
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
107
860
1.30
1.62
1.2
1.2
u/ml
3.8
1.5
0.32
17
210
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
32
2.52
1.60
1.0
1.5
—
290.0
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
25
154
1.65
1.52
1.6
1.5
iu/ml
0.0
0.1
—
7
27
(3035320) C reactive protein [Mass/volume] in Body fluid
7
27
2.61
1.52
2.6
2.1
—
—
—
0
0
(3004451) EKG impression Narrative
6
21
2.88
1.51
1.7
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
21
2.88
1.51
2.8
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
127
1054
1.26
1.49
1.7
1.7
pmol/l
64078144.7
12987447.3
0.36
103
847
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
38
2.39
1.46
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
38
2.39
1.46
1.2
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
16
3.14
1.44
1.2
2.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
22
2.74
1.43
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
40
2.27
1.40
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
7
29
2.43
1.39
2.0
2.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
53
2.10
1.39
1.2
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
41
2.21
1.37
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
45
325
1.42
1.37
3.8
3.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
149
1275
1.23
1.33
6.2
4.0
estimate
0.0
0.0
0.00
58
418
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
472
4507
1.25
1.31
5.5
4.5
mmol/l
4.4
4.6
5.16
435
4074
(3044007) Cell count panel - Peritoneal fluid
5
18
2.79
1.28
1.2
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
10
48
2.10
1.28
2.3
2.5
nmol/l
15.6
3.2
—
10
48
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
468
4469
1.24
1.27
5.4
4.4
mmol/l
1.4
1.5
4.96
429
4008
(3024263) Appearance of Synovial fluid
6
25
2.41
1.24
1.8
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
141
1212
1.22
1.20
5.4
3.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
20
2.51
1.15
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
41
303
1.38
1.12
1.2
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
51
1.98
1.11
1.1
1.4
nmol/l
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
32
2.20
1.08
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
32
2.20
1.08
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
32
2.20
1.08
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
33
2.13
1.06
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
33
2.13
1.06
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
33
2.13
1.06
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
75
1.75
1.03
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
33
240
1.40
1.01
5.8
4.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
115
1.58
1.00
2.6
2.6
ug/min
171.8
94.7
—
9
69
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
208
1880
1.17
0.99
4.8
5.3
ug/l
2.3
3.4
1.33
185
1661
(3017732) Neutrophils [#/volume] in Blood
39
293
1.35
0.99
3.2
3.1
e9/l
4.3
3.9
0.49
29
214
(3032773) Endomysium IgG Ab [Titer] in Serum
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
29
2.08
0.89
3.8
3.2
—
—
—
0
0
(1002224) Polysomnography panel
7
129
0.54
0.89
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
30
2.01
0.87
2.7
2.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
193
1751
1.15
0.87
5.8
4.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
35
265
1.34
0.86
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
120
1.52
0.86
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
120
1.52
0.86
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
121
1.50
0.83
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
477
4619
1.18
0.81
6.0
5.0
mmol/l
2.5
2.7
4.05
441
4140
(3003327) Ova and parasites identified in Stool by Light microscopy
17
114
1.51
0.80
1.8
1.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
33
1.83
0.79
1.2
2.0
mmol/l
6.5
7.1
—
6
19
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.3
—
2.2
—
0
12
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
98
1.54
0.79
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
41
514
0.78
0.78
1.6
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
65
544
1.22
0.75
2.5
4.3
ug/l
3.1
37.7
1.56
53
457
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
450
4347
1.15
0.75
32.8
13.3
ml/min/173m2
66.4
75.9
11.84
406
3603
(4281824)
9
54
1.68
0.75
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
55
1.65
0.73
3.7
4.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
7
38
1.85
0.73
2.3
2.2
ug/l
2.4
2.3
—
7
31
(3026470) Cobalt [Mass/volume] in Blood
7
38
1.85
0.73
2.3
2.3
ug/l
4.3
3.8
—
7
32
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
296
0.73
0.70
1.7
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
130
1441
0.87
0.67
3.0
2.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
62
524
1.21
0.67
1.2
1.3
—
—
—
0
0
(4268621)
7
43
1.64
0.67
2.3
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
224
1.31
0.66
1.1
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
29
224
1.31
0.66
1.1
1.3
u/ml
120.6
172.8
0.51
29
205
(3020891) Body temperature
26
199
1.32
0.63
3.8
4.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.6
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
105
1.44
0.60
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
6
38
1.58
0.54
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
97
0.61
0.52
1.8
1.4
—
—
—
0
0
(4034850)
10
145
0.68
0.51
21.6
10.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
201
0.74
0.50
1.5
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
73
646
1.15
0.49
4.5
4.5
%
33.1
32.3
0.29
62
417
(3008898) HLA-B27 [Presence]
8
117
0.68
0.46
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
103
1.37
0.45
1.1
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
497
4881
1.12
0.43
23.1
10.4
u/l
23.9
24.8
1.06
481
4658
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
14
104
1.35
0.43
1.9
1.5
pmol/l
97.9
389.0
1.20
14
104
(3005570) Glucose [Moles/volume] in Urine
8
56
1.43
0.42
1.5
2.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
176
1.26
0.42
1.4
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
14.9
—
1744.3
—
0
15
(3020874) Milk IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.2
—
0
7
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
12.0
—
924.7
—
0
15
(3036071) Salmonella sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
59
1.36
0.41
1.3
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
104
0.67
0.39
1.1
1.7
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
19
0.00
0.39
0.0
4.2
—
75.5
—
0
14
(3001019) Free T4 and TSH panel - Serum or Plasma
9
124
0.72
0.35
1.3
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
73
1.38
0.34
1.0
1.1
—
—
—
0
0
(4024509)
6
44
1.37
0.34
1.5
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
11
82
1.35
0.34
1.4
1.6
iu/l
2.5
4.5
—
6
24
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
136
1.26
0.34
1.7
1.7
mg/l
2.5
2.6
0.04
12
101
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
109
1.29
0.33
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
46
1.31
0.33
1.8
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
46
1.31
0.33
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
175
0.80
0.31
1.1
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
48
429
1.13
0.31
1.3
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
159
1509
1.07
0.30
4.2
4.6
%
21.8
21.6
0.05
79
817
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
238
0.83
0.29
1.2
1.2
iu/ml
37.4
130.9
—
5
100
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
23
195
1.19
0.28
1.7
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
65
1.23
0.27
1.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
178
1.19
0.26
1.9
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
131
1242
1.07
0.26
1.8
1.6
mmol/l
1.4
1.3
0.66
115
1004
(3007461) Platelets [#/volume] in Blood
508
5024
1.09
0.25
52.8
21.2
e9/l
239.5
242.1
0.38
497
4859
(3024731) MCV [Entitic volume]
508
5025
1.09
0.24
52.6
21.1
fl
92.5
91.6
3.79
500
4918
(3035941) MCH [Entitic mass]
508
5025
1.09
0.24
52.5
21.1
pg
30.5
30.4
0.73
500
4917
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
26
227
1.15
0.24
1.7
3.3
u/ml
42.0
90.4
1.00
26
219
(3010813) Leukocytes [#/volume] in Blood
508
5026
1.08
0.24
52.9
21.2
e9/l
7.1
6.7
4.37
494
4841
(3026361) Erythrocytes [#/volume] in Blood
508
5026
1.08
0.24
52.7
21.2
e12/l
4.2
4.4
15.00
494
4842
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
15
124
1.22
0.24
1.1
1.2
—
2.3
—
0
15
(3000963) Hemoglobin [Mass/volume] in Blood
508
5028
1.08
0.23
53.2
21.3
g/l
127.4
134.5
18.53
501
4914
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
12
0.00
0.21
0.0
1.9
—
2.9
—
0
5
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(4010399)
32
354
0.90
0.20
1.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
104
992
1.06
0.18
5.6
4.2
kg/l
1.0
1.0
0.63
21
145
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
61
1.15
0.17
1.7
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
272
1.11
0.17
2.4
2.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
102
1.18
0.15
1.1
1.2
—
1.7
—
0
9
(40768800) Prostate Pathology biopsy report
14
121
1.16
0.15
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
457
4528
1.04
0.14
5.5
4.7
mmol/l
5.9
6.0
0.24
413
4023
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
15
132
1.14
0.13
1.1
1.2
—
1.1
—
0
6
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
104
1.16
0.12
1.2
1.9
nmol/l
39.6
44.3
0.30
12
97
(3000492) Spirometry study
39
366
1.07
0.12
1.6
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
11
96
1.15
0.10
1.1
1.2
—
30.7
—
0
9
(4146454)
5
44
1.14
0.10
2.0
2.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
45
1.11
0.10
3.2
3.5
u/ml
31.3
37.3
—
5
45
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
113
1103
1.03
0.08
3.1
3.2
ug/l
0.7
0.8
0.43
85
797
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
64
1.09
0.08
1.6
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
2.8
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
104
0.86
0.06
1.7
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
129
0.93
0.03
5.7
5.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
64
648
0.99
0.01
12.5
7.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
17
166
1.02
0.00
2.4
3.6
mmol/l
3.9
4.0
0.16
17
155
(3003338) MCHC [Mass/volume]
366
3661
1.00
0.00
47.7
19.0
g/l
329.1
331.6
5.52
361
3634
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
14.7
—
0
6
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
66.2
—
0
6
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
1.1
—
0
6
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
66
0.91
0.00
1.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
9
93
0.97
0.00
2.4
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
65
0.92
0.00
1.0
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
65
0.92
0.00
1.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
53
0.94
0.00
1.0
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
55
0.91
0.00
1.4
1.1
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
61
0.98
0.00
1.2
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
66
0.91
0.00
1.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
61
0.98
0.00
1.0
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
59
0.85
0.00
3.6
3.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_AMYLNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_AMYLNAS | 5.481 [4.42, 6.8] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.681 |
During the follow-up period (1.1.1998 — 31.12.2019), 696 out of 1370 females with E4_AMYLNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_AMYLNAS | 4.06 [3.17, 5.2] | < 0.001 |
| Birth year | 0.985 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 668 out of 1241 males with E4_AMYLNAS died.
Mortality risk
Mortality risk for people of age
years, who have E4_AMYLNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.4% | 0.707% |
| 5 | 3.508% | 4.19% |
| 10 | 8.544% | 10.612% |
| 15 | 15.418% | 19.136% |
| 20 | 27.346% | 30.589% |
Relationships between endpoints
↥Index endpoint: E4_AMYLNAS – Amyloidosis, other/unspecified
GWS hits: 12
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data